Health
I-Mab Announces Encouraging Phase 1b/2 Study Results of Patients with Advanced NSCLC Receiving Uliledlimab and Toripalimab Combination Therapy at ASCO 2023
- Uliledlimab is a differentiated monoclonal antibody designed to target CD73 and promote stronger activation ofpatients' immune system against cancer cells. - In newly diagnosed patients who were not eligible for or declined chemotherapy treatment, 63% of the patients with CD73High and PD-L1 T...
2023-05-26 05:01
2089
Invivoscribe Announces Updated Reimbursement for the LeukoStrat CDx FLT3 Mutation Assay to Select Newly Diagnosed FLT3-ITD Positive AML Patients Eligible for VANFLYTA in Japan
SAN DIEGO, May 26, 2023 /PRNewswire/ -- Invivoscribe is pleased to announce that their LeukoStrat CDxFLT3 Mutation Assay® has received updated reimbursement byJapan's Ministry of Health, Labor and Welfare (MHLW) to aid in the selection of patients with newly diagnosedFLT3-ITD positive acute my...
2023-05-26 05:00
2021
Lunit Demonstrates Predictive Value of AI-Biomarker Platform at the 2023 ASCO Annual Meeting
- New studies reveal Lunit SCOPE's impact on predicting clinical outcomes, analyzing tumor microenvironment, and enhancing personalized cancer treatment SEOUL, South Korea, May 25, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a global leader of AI-powered cancer diagnostics and therapeutics soluti...
2023-05-26 05:00
1999
TORRAS launches innovative new wearable air conditioner, COOLIFY 3
NEW YORK, May 25, 2023 /PRNewswire/ -- COOLIFY has revolutionized portable cooling devices with the introduction of COOLIFY 3, the latest innovation in wearable air conditioners. Designed to provide a cool and comfortable experience, even in scorching temperatures, COOLIFY 3 incorporates cutting-...
2023-05-25 22:58
2360
Hepagene Therapeutics to Present at the European Association for the Study of the Liver (EASL) Congress 2023
SHANGHAI, May 25, 2023 /PRNewswire/ -- Hepagene Therapeutics, Inc., a clinical stage biopharmaceutical company focusing on developing novel therapies for patients with chronic liver diseases, today announced that Hepagene will present two posters highlighting the preclinical and clinical developm...
2023-05-25 22:00
1900
Leading New Zealand cancer research 'super-charged' by data privacy startup
DUNEDIN, New Zealand, May 25, 2023 /PRNewswire/ -- Two top medical research and biotech innovators today announce a partnership that will supercharge cancer research while providing new levels of health data privacy. Amaroq Therapeutics, a world-leading company based in New Zealand focused on de...
2023-05-25 21:00
1880
Tantech's Successful Exhibition in the NRA Show Increased Brand Visibility Within Industry
LISHUI, China, May 25, 2023 /PRNewswire/ -- Tantech Holdings Ltd (NASDAQ: TANH) ("Tantech" or the "Company") today announced that its subsidiary, EPakia Inc., made a successful presentation at the 2023 National Restaurant Association (NRA) Show. The NRA Show is sponsored by the National Restaura...
2023-05-25 20:30
3340
Telix to Host Briefing with U.S. Leadership Team and Key Opinion Leaders to Highlight Innovation in Urology
June 21, 2023, at The Yale Club, New York City The Company will showcase its urologic pipeline, development of novel therapeutics, imaging agents and technologies that aim to harness the power of targeted radiation at every step of the patient journey MELBOURNE, Australia and INDIANAPOLIS, May 2...
2023-05-25 19:00
1819
HanAll Biopharma and Daewoong Pharmaceutical Enter into Co-Development Agreement with NurrOn Pharmaceuticals to Develop Therapy for Parkinson's Disease
* HanAll Biopharma and Daewoong Pharmaceutical will co-develop NurrOn Pharmaceuticals' novel investigational compounds, including its lead asset ATH-399A, targeting Nurr1 for the treatment of Parkinson's disease (PD), as well as other neurodegenerative disorders * Phase 1 clinical trial is ex...
2023-05-25 19:00
2135
Partnership between Thermo Fisher Scientific and BRIN to Strengthen Research Infrastructure and Capabilities in Indonesia
Collaboration to enhance BRIN's scientific and innovation infrastructure and talent SINGAPORE, May 25, 2023 /PRNewswire/ -- Thermo Fisher, the world leader in serving science, has signed a Memorandum of Understanding ("MOU") with the National Research and Innovation Agency ofIndonesia (BRIN, Bad...
2023-05-25 18:04
2685
Tianlong Helps Hospitals in Thailand Detect Hepatitis Early with Molecular Diagnostic Solution
XI'AN, China, May 25, 2023 /PRNewswire/ -- Tianlong
2023-05-25 16:42
2662
AffaMed Therapeutics Announces Partner Allgenesis Reports Encouraging Preliminary Safety and Efficacy Data from the AG-73305 Phase 2a Trial for the Treatment of Diabetic Macular Edema
* AG-73305 was found to be safe and tolerable with no severe adverse effects (SAEs) after a single intravitreal injection of 0.5 mg and 1 mg in DME patients. * AG-73305 showed median improvements in Best Corrected Visual Accuity (BCVA) of 8.5 ETDRS letters with median Central Subfield Thickness...
2023-05-25 15:52
2463
Mindray Introduces Its Smart Hospital Solutions at Hospitalar 2023
SAO PAULO, Brazil, May 25, 2023 /PRNewswire/ -- Mindray, a leading global provider of medical devices and solutions, is attending one of the largest medical equipment exhibitions inSouth America, Hospitalar 2023, from May 23rd to 26th in Sao Paulo, Brazil. The company is demonstrating its latest ...
2023-05-25 15:27
1956
111 to Announce First Quarter 2023 Unaudited Financial Results on June 15, 2023 - Conference Call to Follow
SHANGHAI, May 25, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced that it will report its unaudited financial results ...
2023-05-25 14:05
1827
CGCT2023 The 3rd China Gene and Cell Therapy Innovation Forum will open on 9th-10th. June in Suzhou, China
SHANGHAI, May 25, 2023 /PRNewswire/ -- "If the 20th century was the era of drug therapy, then the 21st century is the era of cell therapy,"George Daley said, a biologist from theUSA. Cell and gene therapies (CGT), represented by CAR-T, have shown tremendous potential in many diseases, especially ...
2023-05-25 12:14
2918
TYK2/JAK1 Inhibitor AC-201 of Accropeutics Bioscience gained Human Research Ethics Committees (HREC) permission for Phase I
SUZHOU, China, May 24, 2023 /PRNewswire/ -- Accropeutics Bioscience announced that its oral small molecule TYK2/JAK1 inhibitor AC-201 has been approved by the Australian Human Research Ethics Committee (HREC) to launch a clinical phase I trial inAustralia. The trial will be a randomized, double-b...
2023-05-25 09:51
1857
Hope for knee osteoarthritis sufferers with advent of global clinical trial.
Paradigm Biopharma launches clinical trial website to support development
program for knee osteoarthritis therapy.
MELBOURNE, Australia, May 25, 2023 /PRNewswire/ -- With the launch of a new
website dedicated to their global clinical trials (https://hope4OA.com
2023-05-25 09:10
2427
Lynk Pharmaceuticals Announces First Cohort of Psoriatic Patients Dosed with LNK01004 in Phase Ib Clinical Study
HANGZHOU, China, May 25, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that it has dosed the first cohort of psoriatic patients in a Phase Ib clinical trial of its innovative drug LNK01004. ...
2023-05-25 08:00
4324
Catalent Adds New Cryogenic Capabilities at Shiga, Japan, Facility to Support Clinical Supply Demand for Cell and Gene Therapy Development
SOMERSET, N.J., May 25, 2023 /PRNewswire/ -- Catalent (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it has expanded the services and capabilities at its facility in Shiga,Japan, to include the storage, kitting, and...
2023-05-25 08:00
5080
RingConn Official Website Has Been Launched on 5.18
WILMINGTON, Del., May 25, 2023 /PRNewswire/ -- RingConn, the innovative wellness brand, is excited to announce the launch of its official website, which was successfully launched onMay 18th. This milestone signifies RingConn's commitment to providing customers with cutting-edge wellness solutions...
2023-05-25 01:00
3044
Week's Top Stories
Most Reposted
Multiple achievements made in China-Hungary BRI conference
[Picked up by 317 media titles]
2024-05-03 06:59
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 295 media titles]
2024-04-30 10:11
Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 287 media titles]
2024-05-03 06:25TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 262 media titles]
2024-05-02 01:21
Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 253 media titles]
2024-04-30 15:13Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
10615
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
2024-04-30 10:11
7522
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
6790
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
6390
